What do systematic reviews say?

SGLT2i vs placebo

SGLT2i showed no clear difference in pancreatitis compared with placebo (low certainty).

• Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes only
  OR 0.85 [0.39, 1.86]
  1 study · 8246 participants
  Low